US2023029326A1PendingUtilityA1

Device for synchronized sound, vibration and magnetic field stimulation

Assignee: ROUND RIVER RES CORPORATIONPriority: Oct 21, 2015Filed: Sep 28, 2022Published: Jan 26, 2023
Est. expiryOct 21, 2035(~9.2 yrs left)· nominal 20-yr term from priority
Inventors:Daniel E. Cohen
A61H 2201/1676A61H 2203/045A61N 2/002A61M 2021/0022A61N 2/008A61N 2/02A61H 2201/1671A61H 23/02A61H 2201/5007A61M 21/02A61H 1/005A61M 2205/50A61M 2021/0055A61M 2021/0027A61H 2203/0456A61H 2201/1654A61H 2201/1626A61H 1/003A61H 2201/10A61H 2201/0149A61H 23/0236A61H 2201/5048H04R 1/028
71
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An apparatus capable of creating synchronized sound, vibration and magnetic field stimulation, for the purpose of habituating and inhibiting brain function while stimulating the human spiritual energy system, is described. The apparatus comprises an amplifier and transducers built into a comfortable seating arrangement including a support structure and a motion platform. The support structure, such as a chair, rests upon the motion platform, which is adapted to impart three-dimensional motion to the support structure. The apparatus uses layered music to create synchronized sounds, vibrations and magnetic fields.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An apparatus capable of transmitting vibrations to a user comprising:
 a support structure configured to support at least a part of the user's body, said support structure including a frame;   a transducer coupled to the frame of the support structure such that the transducer is capable of movement in relation to the frame;   an audio signal source, wherein the transducer receives audio signals having a wide range of audio frequencies from the audio signal source when the apparatus is in use; and   a motion platform supporting the support structure, wherein said motion platform is adapted to provide three-dimensional motion.   
     
     
         2 . The apparatus of  claim 1 , wherein the transducer receives audio signals in a range from about 20 Hz to about 20,000 Hz when the apparatus is in use. 
     
     
         3 . The apparatus of  claim 1 , further comprising a magnetic field conditioner located between the transducer and the user when the apparatus is in use. 
     
     
         4 . The apparatus of  claim 1 , wherein the motion platform comprises a stationary base structure, and an upper structure which moves in relation to the base structure. 
     
     
         5 . The apparatus of  claim 4 , wherein the upper structure comprises a bottom plate and a motor, and wherein the motor acts on the bottom plate to cause the bottom plate to spin in a circle. 
     
     
         6 . The apparatus of  claim 5 , further comprising a motion ring secured to the bottom plate of the motion platform, and a plurality of bearings secured to the stationary base structure, wherein the motion ring rests on the plurality of bearings. 
     
     
         7 . The apparatus of  claim 6 , wherein a thickness of the motion ring varies to create a tilting motion when the bottom plate spins. 
     
     
         8 . The apparatus of  claim 5 , further comprising a flexible track secured to the stationary base structure. 
     
     
         9 . The apparatus of  claim 8 , further comprising a track motor which acts on the flexible track to cause deformation of the flexible track. 
     
     
         10 . The apparatus of  claim 1 , wherein the three-dimensional motion includes a spinning motion and a tilting motion. 
     
     
         11 . The apparatus of  claim 10 , wherein a rate of the spinning motion and a degree of the tilting motion are controllable through software. 
     
     
         12 . A method of reducing a side effect caused by a medicinal agent used to treat an illness of a patient, comprising:
 providing a device comprising a support structure containing an electromagnetic driver; and   using the device to administer sound, vibration, and electromagnetic stimulation to the patient by transmitting an audio signal to the electromagnetic driver while the patient is supported by the support structure.   
     
     
         13 . The method of  claim 12 , wherein the medicinal agent is a pharmaceutical. 
     
     
         14 . The method of  claim 12 , wherein the medicinal agent is a chemotherapeutic agent used for cancer treatment. 
     
     
         15 . The method of  claim 12 , wherein the side effect is selected from the group consisting of hematopoietic toxicity, decreased mobilization of hematopoietic progenitor cells from bone marrow into the peripheral blood, anemia, myelosuppression, pancytopenia, thrombocytopenia, neutropenia, lymphopenia, leukopenia, stomatitis, alopecia, headache, and muscle pain. 
     
     
         16 . The method of  claim 12 , wherein the sound, vibration, and electromagnetic stimulation is administered to the patient in a session having a duration from about 30 minutes to about 180 minutes. 
     
     
         17 . The method of  claim 12 , wherein the sound, vibration, and electromagnetic stimulation is administered to the patient in sessions conducted from three to seven times per week. 
     
     
         18 . A method of improving a clinical outcome for a patient diagnosed with cancer, comprising:
 providing a device comprising a support structure containing an electromagnetic driver; and   using the device to administer sound, vibration, and electromagnetic stimulation to the patient by transmitting an audio signal to the electromagnetic driver while the patient is supported by the support structure.   
     
     
         19 . The method of  claim 18 , wherein the sound, vibration, and electromagnetic stimulation is administered to the patient in a session having a duration from about 30 minutes to about 180 minutes. 
     
     
         20 . The method of  claim 18 , wherein the sound, vibration, and electromagnetic stimulation is administered to the patient in sessions conducted from three to seven times per week. 
     
     
         21 . The method of  claim 18 , wherein the method is conducted in association with a medical treatment of cancer.

Join the waitlist — get patent alerts

Track US2023029326A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.